Article Details

Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety ...

Retrieved on: 2024-06-24 13:44:04

Tags for this article:

Click the tags to see associated articles and topics

Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety .... View article details on hiswai:

Excerpt

Figures 1 through 4 illustrate the reprogramming of the innate immune response after Gemini administration in multiple biomarkers of TLR4 stimulation.

Article found on: www.eagletribune.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up